Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viscosupplementation in Severe Knee Osteoarthritis
NCT03090698Phase 4Unknown
- Sponsor
- Universidade Federal Fluminense
- Start
- Sep 2015
- Primary completion
- Apr 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sodium hyaluronate in osteoarthritis (OA) (3 arms), sponsored by Universidade Federal Fluminense. Primary endpoints: Lysholm Knee Scoring Scale at 1 month and Knee Society Score at 1 month. Status: unknown.
02
Drugs
sodium hyaluronate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03090698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03090698.